Best practice in symptom assessment: A review

Gut

Volumn 53, Issue SUPPL. 4, 2004, Pages

  McColl, E ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE SEVERITY; EPIGASTRIC PAIN; GASTROESOPHAGEAL REFLUX; HEALTH CARE PERSONNEL; HEARTBURN; HUMAN; LITERATURE; PRIORITY JOURNAL; PSYCHOMETRY; QUESTIONNAIRE; REFLUX ESOPHAGITIS; REVIEW; SELF REPORT; SYMPTOMATOLOGY;

DATA COLLECTION; GASTROESOPHAGEAL REFLUX; HUMANS; MEDICAL HISTORY TAKING; MEDICAL RECORDS; PROFESSIONAL PRACTICE; QUESTIONNAIRES; TIME FACTORS;

EID: 2342489383     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2003.034355     Document Type: Review

References (73)

1. Venables TL, Newland RD, Patel AC, et al. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol 1997;32:965-73.
2. Dent J. Definitions of reflux disease and its separation from dyspepsia. Gut 2002;50(suppl IV):iv17-20.
3. Barsky AJ, Cleary PD, Barnett MC, et al. The accuracy of symptom reporting by patients complaining of palpitations. Am J Med 1994;97:214-21.
4. Corley DA, Cello JP, Koch J. Accuracy of endoscopic databases for assessing patient symptoms: comparison with self-reported questionnaires in patients infected with the human immunodeficiency virus. Gastrointest Endosc 2000;51:129-33.
5. Fontaine A, Larue F, Lassauniere JM. Physicians' recognition of the symptoms experienced by HIV patients: how reliable? J Pain Symptom Manage 1999;18:263-70.
6. Justice AC, Rabeneck L, Hays RD, et al. Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms. Outcomes Committee of the AIDS Clinical Trials Group. J Acquir Immune Defic Syndr Hum Retrovirol 1999;21:126-33.
7. Justice AC, Chang CH, Rabeneck L, et al. Clinical importance of provider-reported HIV symptoms compared with patient-report. Med Care 2001;39:397-408.
8. Kwoh CK, Ibrahim SA. Rheumatology patient and physician concordance with respect to important health and symptom status outcomes. Arthritis Rheum 2001;45:372-7.
9. Sandmark S, Carlsson R, Fausa O, et al. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol 1988;23:625-32.
10. Stephens RJ, Hopwood P, Girling DJ, et al. Randomized trials with quality of life endpaints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings? Qual Life Res 1997;6:225-36.
11. Heading RC, Wager E, Tooley PJH. Reliability of symptom assessment in dyspepsia. Eur J Gastroenterol Hepatol 1997;9:779-81.
12. Holmes WF, MacGregor EA, Sawyer JP, et al. Information about migraine disability influences physicians' perceptions of illness severity and treatment needs. Headache 2001;41:343-50.
13. Agreus L, Talley NJ, Svardsudd K, et al. Identifying dyspepsia and irritable bowel syndrome: the value of pain or discomfort, and bowel habit descriptors. Scand J Gastroenterol 2000;35:142-51.
14. Agreus L, Svardsudd K, Nyren O, et al. The epidemiology of abdominal symptoms: prevalence and demographic characteristics in a Swedish adult population. A report from the Abdominal Symptoms Survey. Scand J Gastroenterol 1994;29:102-9.
15. Stanghellini V. Review article: pain versus discomfort - is differentiation clinically useful? Aliment Pharmacol Ther 2001;15:145-9.
16. Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998;33:1023-9.
17. Locke GR, Talley NJ, Weaver AL, et al. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994;69:539-47.
18. Steen IN, McColl E, Hutchinson A. Developing symptom based outcome measures. In: Hutchinson A, McColl E, Christie M, et al, eds. Outcome measures in primary and outpatient care. Reading: Harwood Academic Publishers, 1996:23-44.
19. Shiffman S, Hufford MR, Paty JA. Subject experience diaries in clinical research. Part 1: The patient experience movement. Appl Clin Trials 2001;February:46-56.
20. Junghard O, Lauritsen K, Talley NJ, et al. Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non ulcer dyspepsia. Eur J Surg Suppl 1998;583:106-11.
21. Sandha GS, Hunt RH, Veldhuyzen Van Zanten SJ. A systematic overview of the use of diary cards, quality-of-life questionnaires, and psychometric tests in treatment trials of Helicobacter pylori-positive and -negative non-ulcer dyspepsia. Scand J Gastroenterol 1999;34:244-9.
22. Leibbrand R, Cuntz U, Hiller W. Assessment of functional gastrointestinal disorders using the Gastro-Questionnaire. Int J Behav Med 2002;9:155-72.
23. Pope CE. The quality of life following antireflux surgery. World J Surg 1992;16:355-8.
24. Rattner DW, Brooks DC. Patient satisfaction following laparoscopic and open antireflux surgery. Arch Surg 1995;130:289-93.
25. Revicki DA, Wood M, Wiklund I, et al. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 1998;7:75-83.
26. Rothman M, Farup C, Stewart W, et al. Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials. Dig Dis Sci 2001;46:1540-9.
27. Rush DR, Stelmach WJ, Young TL, et al. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study. J Fam Pract 1995;41:126-36.
28. Shaw M, Talley NJ, Adlis S, et al. Development of a digestive health status instrument: tests of scaling assumptions, structure and reliability in a primary care population. Aliment Pharmacol Ther 1998;12:1067-78.
29. Svedlund J, Sjodin I, Dotevall G. GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129-34.
30. Velanovich V, Vallance SR, Gusz JR, et al. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 1996;183:217-24.
31. Burman ME. Health diaries in nursing research and practice. Image J Nurs Sch 1995;27:147-52.
32. Hyland ME, Kenyon CA, Allen R, et al. Diary keeping in asthma: comparison of written and electronic methods. BMJ 1993;306:487-9.
33. Hyland ME, Crocker GR. Validation of an asthma quality of life diary in a clinical trial. Thorax 1995;50:724-30.
34. Hufford MR, Shiffman S. Methodological issues affecting the value of patient-reported outcomes data. Expert Rev Pharmocoeconomics Outcomes Res 2002;2:119-28.
35. Stone AA, Shiffman S, Schwartz JE, et al. Patient non-compliance with paper diaries. BMJ 2002;324:1193-4.
36. Roghmann KJ, Haggerty RJ. The diary as a research instrument in the study of health and illness behavior: experiences with a random sample of young families. Med Care 1972;10:143-63.
37. Verbrugge LM. Health diaries. Med Care 1980;18:73-95.
38. Dahlquist G, Wall S, Ivarsson JI, et al. Health problems and care in young families - an evaluation of survey procedures. Int J Epidemiol 1984;13:221-8.
39. Feine JS, Lavigne GJ, Dao TT, et al. Memories of chronic pain and perceptions of relief. Pain 1998;77:137-41.
40. Price DD, Milling LS, Kirsch I, et al. An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain 1999;83:147-56.
41. Bradburn NM, Rips LJ, Shevell SK. Answering autobiographical questions: The impact of memory and inference on surveys. Science 1987;236:157-61.
42. Bradburn NM. Temporal representation and event dating. In: Stone AA, Turkkan JS, Bachrach C, et al, eds. The science of self-report: implications for research and practice. Mahwah, NJ: Lawrence Eribaum Associates Inc, 2000:49-61.
43. Steen IN, Hutchinson A, McColl E, et al. Development of a symptom-based outcome measures for asthma. BMJ 1994;309:1065-9.
44. Carp FM, Carp A. The validity, reliability and generalizability of diary data. Exp Aging Res 1981;7:281-96.
45. Sudman S, Lannam LB. Health care survey using diaries. Washington DC: National Center for Health Services Research, USDHHS, 1980 (PHS Research Report Series PHS 80-3279).
46. Rakowski W, Julius M, Hickey T, et al. Daily symptoms and behavioral responses. Results of a health diary with older adults. Med Care 1988;26:278-97.
47. Kimble LP, Dunbar SB, McGuire DB, et al. Cardiac instrument development in a low-literacy population: the revised Chest Discomfort Diary. Heart Lung 2001;30:312-20.
48. Norman GR, McFarlone AH, Streiner DL, et al. Health diaries: strategies for compliance and relation to other measures. Med Care 1982;20:623-9.
49. Hufford MR, Stone AA, Shiffmon S, et al. Paper vs. Electronic diaries: compliance and subject evaluations, Appl Clin Trials 2002;August:38-43.
50. Bentzen N, Christionsen T, McColl E, et al. Selection and cross-cultural adaptation of health outcome measures. Eur J Gen Pract 1998;4:27-33.
51. Kirshner B, Guyatt G. A methodological framework for assessing health indices. J Chronic Dis 1985;38:27-36.
52. Wyrwich KW, Stoebler Tardino VM. A blueprint for symptom scales and responses: measurement and reporting. Gut 2004;53(suppl IV):iv45-8.
53. Dillman DA. Mail and telephone surveys: The total design method. New York: John Wiley and Sons Inc, 1978.
54. Dillman DA. Mail and internet surveys: the tailored design methods. New York: John Wiley and Sons Inc, 2000.
55. Jenkins CR, Dillman DA. Towards a theory of self-administered questionnaire design. In: Lyberg L, Biemer P, Collins M, et al, eds. Survey measurement and process quality. New York: John Wiley and Sons Inc, 1997:165-96.
56. Edwards P, Roberts I, Clorke M, et al. Increasing response rates to postal questionnaires: systematic review. BMJ 2002;324:1183-91.
57. Sudman S, Bradburn N. Asking questions: a practical guide to questionnaire design. San Francisco: Jossey-Bass, 1982.
58. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. Oxford: Oxford University Press, 1989.
59. Booth MI, Stratford J, Dehn TCB. Patient self-assessment of test-day symptoms in 24-h pH-metry for suspected gastroesophageal reflux disease. Scand J Gastroenterol 2001;36:795-9.
60. Gold DR, Weiss ST, Tager IB, et al. Comparison of questionnaire and diary methods in acute childhood respiratory illness surveillance. Am Rev Respir Dis 1989;139:847-9.
61. Kuykendall DH, Rabeneck L, Campbell CJ, et al. Dyspepsia: how should we measure it? J Clin Epidemiol 1998;51:99-106.
62. Keefe F. Self-report of pain: issues and opportunities. In: Stone AA, Turkkan JS, Bachrach C, et al, eds. The science of self-report: implications for research and practice. Mahwah, NJ: Lawrence Erlbaum Associates Inc, 2000:317-37.
63. Fayers P, Machin D. Quality of life: assessment, analysis and interpretation. Chichester: John Wiley and Sons Inc, 2000.
64. Fairclough DL. Design and analysis of quality of life studies in clinical trials: interdisciplinary statistics. Boca Raton, FL: Chapman and Hall/CRC, 2002.
65. Rowan K. Global questions and scares. In: Jenkinson C, ed. Measuring health and medical outcomes. London: UCL Press, 1994:54-76.
66. Tourangeau R, Rips LJ, Rosinski K. The psychology of survey response. Cambridge: Cambridge University Press, 2000.
67. Ziebland S, Fitzpatrick R, Jenkinson C, et al. Comparison of two approaches to measuring change in health status in rheumatoid arthritis: the Health Assessment Questionnaire (HAQ) and modified HAQ. Ann Rheum Dis 1992;51:1202-5.
68. Crabtree HL, Hildreth AJ, O'Connell JE, et al. Measuring visual symptoms in British cataract patients: the cataract symptom scale. Br J Ophthalmol 1999;83:519-23.
69. Hagg O, Fritzell P, Oden A, et al. Simplifying outcome measurement: evaluation of instruments for measuring outcome after fusion surgery for chronic low back pain. Spine 2002;27:1213-22.
70. Russell ML, Preshaw RM, Bront RF, et al. Disease-specific quality of life: the Gallstone Impact Checklist. Clin Invest Med 1996;19:453-60.
71. Talley NJ, Verlinden M, Jones M. Validity of a new quality of life scale for functional dyspepsia: a United States multicenter trial of the Nepean Dyspepsia Index. Am J Gastroenterol 1999;94:2390-7.
72. Juniper EF, Guyatt GH, Willan A, et al. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994;47:81-7.
73. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407-15.